NewGenIvf Group Limited

NASDAQ: NIVF · Real-Time Price · USD
1.87
-0.05 (-2.60%)
At close: Aug 15, 2025, 3:00 PM

NewGenIvf Income Statement

Financials in USD. Fiscal year is undefined.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
5.43M 5.14M 5.94M 4.12M
Cost of Revenue
3.61M 3.45M 4.41M 3.09M
Gross Profit
1.83M 1.68M 1.54M 1.02M
Operating Income
-1.16M 42.24K -504.91K 198.76K
Interest Income
6.95K 518.00 21.00 63.00
Pretax Income
-961K 108.42K 500.65K 156.18K
Net Income
-525K 130.19K 458.67K -533
Selling & General & Admin
2.99M 1.64M 1.14M 826.02K
Research & Development
n/a n/a n/a n/a
Other Expenses
-186.39K n/a 64.00 n/a
Operating Expenses
2.8M 1.64M 1.14M 826.02K
Interest Expense
778.66K 46.18K 77.76K 88.29K
Selling & Marketing Expenses
206.31K 18.03K 36.19K 24.69K
Cost & Expenses
6.59M 5.09M 5.54M 3.92M
Income Tax Expense
-487K -799K 208.14K 294.72K
Shares Outstanding (Basic)
569.25K 253.73K 193.69K 50.74M
Shares Outstanding (Diluted)
569.25K 253.73K 193.69K 50.74M
EPS (Basic)
-23.05 12.85 64.60 -0.01
EPS (Diluted)
-23.05 12.85 64.60 -0.01
EBITDA
24.11K 384.31K 725.69K 587.01K
EBIT
-182K 154.6K 421.75K 244.47K
Depreciation & Amortization
206.26K 229.71K 303.94K 342.54K